CAAS [CHINA AUTOMOTIVE SYSTEMS] 10-Q: (Original Filing)

[FORM 10-Q (Mark one) x For the quarterly period ended September 30, 2009 Or ¨ For the transition period from ________ to _________ China Automotive Systems, Inc. specified in its charter) Delaware 33-0885775 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) No. 1 Henglong Road, Yu Qiao Development Zone, Shashi District, Jing Zhou City, Hubei Province,] [CERTIFICATION I, Qizhou Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Jie Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CHINA AUTOMOTIVE SYSTEMS, INC. 18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Qizhou Wu Chief Executive Officer EX-32.1 4 v165278_ex32-1.htm] [CHINA AUTOMOTIVE SYSTEMS, INC. 18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jie Li Chief Financial Officer EX-32.2 5 v165278_ex32-2.htm]

By | 2016-03-28T19:08:39+00:00 November 12th, 2009|Categories: CAAS, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: (Original Filing)

[China Automotive Systems Reports 2009 Third Quarter Results - , - Q3 EPS $0.28 - Free Cash Flow $15.5 million in first 9 months - WUHAN, China, November 12, 2009 -- China Automotive Systems, Inc., (the "Company"), (NASDAQ: CAAS) 2009 Third Quarter Highlights: -- Net sales increased organically 75% YoY to a new quarterly sales record of $64.7 million; --] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event reported): November 12, 2009 (November 12, 2009) China Automotive Systems, Inc. Delaware 000-3123 33-0885775 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Identification No.) No. 1 Henglong Road, Yu Qiao Development Zone Shashi District, Jing Zhou City Hubei Province People’s Republic of China (86) 27-5981]

By | 2016-03-28T19:11:39+00:00 November 12th, 2009|Categories: CAAS, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

AMCN [AIRMEDIA] 6-K: (Original Filing)

[AirMedia Announces Unaudited Third Quarter 2009 Financial Results Beijing, China — November 10, 2009 — AirMedia Group Inc. (“AirMedia” or the “Company”) (Nasdaq: AMCN), a leading operator of out-of-home advertising platforms in China targeting mid-to-high-end consumers, today announced its unaudited financial results for the third quarter ended September 30, 2009. Third Quarter 2009 Financial and Business Highlights • Total revenues] [FORM 6-K AIRMEDIA GROUP INC. 17/F, Sky Plaza, þ o Form 20-F o o AIRMEDIA GROUP INC. Herman Man Guo Chairman and Chief Executive Officer 2 3 6-K 1 c92527e6vk.htm FORM 6-K]

By | 2016-03-23T01:38:15+00:00 November 12th, 2009|Categories: AMCN, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

HPJ [Highpower International] 10-Q: (Original Filing)

[HONG KONG HIGHPOWER TECHNOLOGY, INC. FORM 10-Q For the Quarterly Period Ended September 30, 2009 INDEX Page Part I Financial Information Item 1. Financial Statements (a) Balance Sheets as of September 30, 2009 (Unaudited) and December 31, 2008 2] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Dang Yu Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Hong Kong Highpower Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Henry Ngan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Hong Kong Highpower Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dang Yu Pan Chairman of the Board and Chief Executive Officer November 12, 2009 Henry Ngan Chief Financial Officer (Principal Financial and Accounting Officer) November 12, 2009 EX-32.1 4 v165765_ex32-1.htm]

DHRM [Dehaier Medical Systems] S-1: (Original Filing)

[¨ Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company x CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered (1) Proposed Maximum Amount of Common Shares (2) $13,500,000 $753.30 (3) $1,620,150 $90.40 Total $15,120,150 $843.70 (4) (1) (2) (3) (4) Paid herewith. SUBJECT TO COMPLETION, DATED NOVEMBER 11, 2009 Registration Statement] [DEHAIER MEDICAL SYSTEMS LIMITED (a British Virgin Islands company) Minimum Offering: 1,250,000 Common Shares Maximum Offering: 1,500,000 Common Shares ($_____ per share) PLACEMENT AGREEMENT Anderson & Strudwick, Incorporated 707 East Main Street, 20 th Floor Richmond, Virginia 23219 Ladies and Gentlemen: Introduction 1. 2. Registration Statement and Prospectus (a) further amendments thereto will conform, in all material respects to the] [TERRITORY OF THE BRITISH VIRGIN ISLANDS THE BVI BUSINESS COMPANIES ACT, 2004 AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF DEHAIER MEDICAL SYSTEMS LIMITED A COMPANY LIMITED BY SHARES 1. REGISTERED SHARES 1.1 1.2 Any Shareholder receiving a certificate shall indemnify and hold the Company and its directors and officers harmless from any loss or liability which it or they may] [TERRITORY OF THE BRITISH VIRGIN ISLANDS THE BVI BUSINESS COMPANIES ACT, 2004 AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF Dehaier Medical Systems Limited A COMPANY LIMITED BY SHARES 1. DEFINITIONS AND INTERPRETATION 1.1 In this Memorandum of Association and the attached Articles of Association, if not inconsistent with the subject or context: Act “ Articles “ Board “ business day] [DEHAIER MEDICAL SYSTEMS LIMITED ____________ ____, _____ Anderson & Strudwick, Incorporated 707 East Main Street 20 th Floor Richmond, Virginia 23219 Ladies and Gentlemen: 1. Notices of Record Date 2. No Impairment 3. 4. Exercise for Cash (a) Cashless Exercise (b) 2 Issuance of Certificates (c) Current Value (d) 3 Protection Against Dilution 5. Dividends, Subdivisions, Reclassifications, Etc (a) 4] [Serial. No:________________ Labor Contract Dehaier Medical Technology Ltd. Party A: Party B: LABOR CONTRACT Dehaier Medical Technology Co. Ltd. (hereinafter referred to as “Party A”) and Name of Employee: _______ Identification Card No.: _________ (hereinafter referred to as “Party B”) hereby execute this Contract in accordance with the applicable provisions of “The Labor Law of the People’s Republic of China”] [LOCK-UP AGREEMENT ________ ___,____________ By Facsimile (____________) By Facsimile ((804) 648-3404) Dehaier Medical Systems Limited Anderson & Strudwick, Incorporated 1223 Epoch Center 707 East Main Street No. 31 Zi Zhu Yuan Road 20 th Floor Haidian District, Beijing 100089 Richmond, Virginia 23219 People’s Republic of China Attn: L. McCarthy Downs, III, Attn: Ping Chen Senior Vice President CEO Re: Lock-Up] [DEHAIER MEDICAL SYSTEMS LIMITED 2009 SHARE INCENTIVE PLAN Purpose and Effective Date 1. (a) The purpose of the Dehaier Medical Systems Limited 2009 Share Incentive Plan (the “Plan”) is to further the long term stability and financial success of Dehaier Medical Systems Limited (the “Company”) by attracting and retaining personnel, including employees, non-employee directors, and consultants, through the use of] [List of Subsidiaries Dehaier Medical Systems Limited Subsidiary (Hong Kong): De-haier Medical Systems (Hong Kong) Limited Subsidiaries (PRC) Affiliate (PRC) Beijing Dehaier Technology Company Limited (controlled by certain executive officers; owns approximately 3.63% of PRC subsidiary)] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on to Form S-1 of our report dated November 11, 2009 relating to the consolidate financial statements of Dehaier Medical Systems Limited and Affiliate and to the reference to our Firm under the caption “Experts” in the Prospectus. New York, New York] [DEHAIER MEDICAL SYSTEMS LIMITED CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics covers a wide range of business practices and procedures. It does not cover every issue that may arise, but it sets out basic principles to guide the employees of Dehaier Medical Systems Limited and its subsidiaries (the “Company”). All of our employees must] [November 6, 2009 Dehaier Medical Systems Limited. 1223 Epoch Center No. 31 Zi Zhu Yuan Road Haidian District, Beijing 100089 People’s Republic of China Dear Sirs, “PRC”) We are qualified lawyers of the People’s Republic of China (the Company “Registration Statement”), SEC Securities Act Shares We have acted as PRC counsel for Dehaier Medical Systems Limited, a company incorporated under]

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Skystar to Present at the Brean Murrayrret & 2009 China Growthnference XI'AN, CHINA November 11 , 2009ystar Bio-Pharmaceuticalmpanyystar@tpg-ir.com To request a one-on-one meeting or to beded toystars email list, pleasentact Brandi Floberg atoutystar Bio-Pharmaceuticalmpany http://www.skystarbio-pharmaceutical.comystar is a China-based developer and distributor of veterinary healthcare and medicalre products.ystar has four product lines (veterinary medicines, micro-organisms, vaccines]

By | 2016-02-05T04:55:56+00:00 November 12th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharma Holdings, Inc., certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharma Holdings, Inc., certify that: 1) I have reviewed this quarterly report on Form 10-Q of China Pharma Holdings, Inc; 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2009 as filed with the Zhilin Li material respects, the financial condition and result of operations of the Company. Zhilin Li Chief Executive Officer EX-32.1 4 cph10qex321093009.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the for the period ended September 30, 2009 as filed with the Frank Waung Chief Financial Officer EX-32.2 5 cph10qex322093009.htm]

By | 2016-03-03T21:22:38+00:00 November 10th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar